With worldwide sales and distribution channels, Fluke Biomedical anticipates growth through innovative design and creative solutions for its customers. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface."įluke Biomedical leads the world in the manufacture of biomedical test and simulation products, including electrical safety testers, patient simulators, performance analyzers, and fully integrated and automated performance testing and documentation systems. "We have experience in highly specialized markets all over the world, we know our business and we can now maximize our competencies. "The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners," said Magnus Kristoferson, CEO of Unfors RaySafe. Both companies see the user-friendliness of their products, combined with advanced technology and maximum measurement accuracy as their major assets.
#Fluke biomedical software#
With an enhanced portfolio especially in the fields of diagnostic x-ray, real time dose monitoring systems for medical personnel, and patient dose tracking software solutions, the Unfors RaySafe product line will broaden Fluke Biomedical's customer base and answer market demands with innovative and state-of-the-art solutions.įluke Biomedical's goal with this acquisition is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment. With this acquisition Fluke Biomedical adds industry leading quality assurance devices for diagnostic x-ray from Unfors RaySafe to its product offering.
5, 2014 (ANTARA/PRNewswire) - Fluke Biomedical, the world's leading manufacturer of biomedical test instruments, announced today the acquisition of Unfors RaySafe.
0 kommentar(er)
